Skip to main content
OpenTrials
Completed

NCT Number: NCT06242665

You Are What You Eat: Food as a Risk Factor and a Treatment for Depression

This study experimentally investigates 1) whether ultra processed food (UPF) intake contributes to depression by increasing low mood and poor sleep due to blood glucose fluctuations (which then increases the desire to consume more UPFs) and 2) to investigate the effectiveness of a 2-week meal-kit intervention that provides convenient and tasty minimally processed foods (MPF) to reduce depression. The following aims and hypotheses are tested:

Aim 1: To investigate whether UPF intake and low mood contribute to each other in a cyclical fashion through the mechanisms of blood glucose fluctuations and disrupted sleep in individuals with moderate-to-severe depression.

H1: It is hypothesized that UPF intake and high blood glucose will be associated with low mood in individuals with depression.

Aim 2: To establish an industry partnership to investigate whether commercially available meal kit delivery reduces symptoms of depression in individuals with moderate-to-severe depression relative to a nutrition education control condition.

H2: Meal kit delivery will lead to reductions in depression symptoms and daily reductions in low mood relative to the control condition (nutrition guidance only).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

About this study

The study will include a combination of in-person, at-home, and virtual activities over the course of ~21 days (contingent on scheduling, this duration may vary and particularly between in-person visits #1 and #2). Participants complete three in-lab visits, each followed by a week of remote data tasks (e.g., ecological momentary assessment, continuous glucose monitoring, and physical activity and sleep tracking (Fitbit)).

During in-lab visit #1, participants will complete questionnaires and interviews, have a continuous glucose monitor inserted, and will have body composition measurements taken (height, weight, Inbody scan). Participants will complete the remote tasks for the following week while eating their typical diet (i.e., baseline period).

During in-lab visit #2, participants will complete questionnaires, interviews, and body composition measurements (height, weight, Inbody scan). Participants are randomly assigned to a meal delivery (will receive two weeks of low UPF meals and nutrition guidance) or control (will receive some snacks and nutrition guidance) condition (i.e., dietary intervention period). Participants will complete the remote tasks for the following two weeks.

During in-lab visit #3, participants will complete questionnaires, interviews, and body composition measurements (height, weight, InBody scan).

Participants are contacted 1- and 6-months later to complete a short follow-up survey and provide information about their current diet.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18+ years of age
  • Must own an Android or iPhone smartphone
  • Must be able to access phone one every 90 minutes
  • Able to attend consent call over zoom or phone
  • Endorsement of a PHQ-8 score of at least 10 assessed at consent
  • Endorsement of a PHQ-8 score of at least 8 assessed 24 hours prior to Visit 1
  • Endorse daily intake of at least UPF foods
  • Willing to come to three in-lab visits
  • Willing to follow dietary guidelines
  • Must be able to speak, write, and read English fluently

Exclusion criteria

  • Regular smoking of cigarettes or vaping of nicotine
  • History of medication that impact reward, eating, or indicate severe mental health conditions (e.g., Lithium)
  • The following medical conditions; Diabetes Type I, Diabetes Type II, Prediabetes, Bipolar Disorder, Schizophrenia, Psychotic Disorder, Depression with psychotic symptoms, Borderline Personality Disorder, Hypoglycemia, Substance use disorder (e.g., alcohol use disorder, opioid use disorder, cannabis use disorder), Obsessive compulsive disorder, and Post-traumatic stress disorder
  • Endorsement of a suicide attempt or having been hospitalized for psychiatric reasons in the last year
  • A diagnosis of a restrictive eating disorder (anorexia nervosa, bulimia nervosa, purging disorder) within the last 5 years
  • History of disorders that impact eating (e.g., cancer, irritable bowel syndrome, inflammatory bowel disease, hypothyroidism).
  • Current pregnancy, breast-feeding, trying to get pregnant, or within six months of having given birth
  • Frequent (i.e., weekly) night shift work or irregular shifts and for abnormal sleep patterns (i.e., wake up time after 11am)

Treatment and study plan

Low UPF Meals (Study Provided)

Other

Meals provided through delivery service

Low UPF Nutritional Guidance

Other

Self-guided instructions from study team.

Low UPF Snacks (Study Provided)

Other

Low UPF snacks provided to participant

Primary outcomes

  1. Low mood symptoms

    Time frame: Assessed during dietary adherence period for 2 weeks

    Depression symptoms (e.g., anhedonia, low energy) will be assessed with the Patient Health Questionnaire (PHQ-8) using ecological momentary assessment and at each study visit. The PHQ-8 scores 8 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Higher PHQ-8 scores indicate greater depression symptoms.

Secondary outcomes

  1. Blood Glucose Level

    Time frame: Assessed during dietary adherence period for 2 weeks

    Assessed using a continuous blood glucose monitor

  2. Sleep Quality

    Time frame: Assessed during dietary adherence period for 2 weeks

    Assessed using a Fitbit

  3. Metabolic Equivalent of Task (METs)

    Time frame: Assessed during dietary adherence period for 2 weeks

    A measure of physical activity engagement assessed using a Fitbit

  4. Feasibility of the Interventions

    Time frame: Assessed post-dietary change during in-lab Visit 3 (1 day)

    Assessed in a qualitative interview at Visit 3

  5. Accessibility of the Interventions

    Time frame: Assessed post-dietary change during in-lab Visit 3 (1 day)

    Assessed in a qualitative interview at Visit 3

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2025
First posted
Feb 5, 2024
Registry last updated
Jul 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.